Log In
Print this Print this

metyrapone (Metopirone)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionInhibitor of endogenous adrenal corticosteroid synthesis
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationCushing's disease
Indication DetailsTreat Cushing's disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today